These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15226620)

  • 1. [Pharmacological and clinical profile of telmisartan, a selective angiotensin II type-1 receptor blocker].
    Chachin M; Ohmura T; Hayashi N; Nishimura Y; Satoh H
    Nihon Yakurigaku Zasshi; 2004 Jul; 124(1):31-9. PubMed ID: 15226620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
    Plosker GL; White WB
    Drugs; 2008; 68(13):1877-99. PubMed ID: 18729541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan.
    McClellan KJ; Markham A
    Drugs; 1998 Dec; 56(6):1039-44; discussion 1045-6. PubMed ID: 9878991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
    Dupuis F; Vincent JM; Limiñana P; Chillon JM; Capdeville-Atkinson C; Atkinson J
    J Hypertens; 2010 Jul; 28(7):1566-73. PubMed ID: 20589978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
    Chazova IE
    Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969
    [No Abstract]   [Full Text] [Related]  

  • 8. Telmisartan: a review of its use in the management of hypertension.
    Battershill AJ; Scott LJ
    Drugs; 2006; 66(1):51-83. PubMed ID: 16398568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.
    Dial S; Nessim SJ; Kezouh A; Benisty J; Suissa S
    Br J Clin Pharmacol; 2014 Nov; 78(5):1151-8. PubMed ID: 24803383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan: a different angiotensin II receptor blocker protecting a different population?
    Burnier M
    J Int Med Res; 2009; 37(6):1662-79. PubMed ID: 20146864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring to assess the comparative efficacy and duration of action of a novel new angiotensin II receptor blocker--telmisartan.
    Neutel JM
    Blood Press Suppl; 2001; 1():27-32. PubMed ID: 11333011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharma-clinics. Medication of the month. Telmisartan (Micardis)].
    Kulbertus H
    Rev Med Liege; 2000 Jan; 55(1):57-60. PubMed ID: 10803040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge.
    Stangier J; Su CA; van Heiningen PN; Meinicke T; van Lier JJ; de Bruin H; Tamminga WJ; Jonkman JH
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):672-85. PubMed ID: 11602814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension].
    Ivanova OV; Fomicheva OA; Sergakova LM; Chernova NA; Rogoza AN; Karpov YA
    Kardiologiia; 2002; 42(2):45-9. PubMed ID: 12494207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan in the treatment of hypertension.
    Rosario BH; Hendra TJ
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):485-92. PubMed ID: 18433350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    Maillard MP; Perregaux C; Centeno C; Stangier J; Wienen W; Brunner HR; Burnier M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?
    Weber M
    J Hypertens Suppl; 2009 Jul; 27(5):S9-14. PubMed ID: 19587555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan: a review of its use in hypertension.
    Sharpe M; Jarvis B; Goa KL
    Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan: just an antihypertensive agent? A literature review.
    Destro M; Cagnoni F; Dognini GP; Galimberti V; Taietti C; Cavalleri C; Galli E
    Expert Opin Pharmacother; 2011 Dec; 12(17):2719-35. PubMed ID: 22077832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.
    Gosse P
    Vasc Health Risk Manag; 2006; 2(3):195-201. PubMed ID: 17326326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.